P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

July 2002

Features

A Cost Analysis of Switching Calcium Channel Blockers: A One-Year Post-formulary Decision Review

Health care professionals at the Martin Army Community Hospital studied the switch from amlodipine to other calcium channel blockers in light of the overall cost of therapy.
Gilda M. Smith, PharmD, Isiah M. Harper, Jr., RPh, Lt. Col. USA, and Allan D. Stowers, MS, BS Pharm

Improving the Quality of Care: A Regional Medication Safety Effort

This article discusses how hospitals in one northeastern region coordinated to create a medication-safety program.
Craig Senholzi, RPh, MBA and Matthew P. Fricker, Jr. MS, RPh

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA.

Meeting Highlights

The 38th Annual Meeting of the American Society of Clinical Oncology

Lawrence M. Prescott, PhD

Continuing Medical Education

The Dangers of Immediate-Release Nifedipine for Hypertensive Crises

The authors discuss why IR nifidepine, which had been the treatment of choice for hypertensive crises, should not be used.
Aliya F. Mansoor, PharmD and Laura von Hagel Keefer, PharmD

Departments

Editorial

My New Heroes

Associate Editor-in-Chief Karl Matuszewski champions the mission of his new heroes.
Karl A. Matuszewski, MS, PharmD

Prescription Washington

Buried “Treasures” in the Bioterrorism Bill

Stephen Barlas

Medication Errors

Bowel Preparations Might Pose Problems in Renal Patients

Matthew Grissinger, RPh, warns about the dangers of excessive doses of bowel preparations.

Drug Forecast

Tenofovir: The First Nucleotide Analog for HIV-1

Evans Branch III, PharmD, Melony Floyd, PharmD, and Marlon Honeywell, PharmD